Search details
1.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38453781
2.
Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer.
Bull Cancer
; 108(9S1): S22-S32, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34955159
Results
1 -
2
de 2
1
Next >
>>